EFFICACY OF OLMESARTAN MEDOXOMIL/AMLODIPINE (OLM/AML) PLUS AMLODIPINE (AML) IN AGE DEFINED SUBGROUPS OF MODERATE-TO-SEVERE HYPERTENSIVE PATIENTS

被引：0
|
作者：
De La Sierra, A. [1 ]
机构：
[1] Univ Barcelona, Barcelona, Spain
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [21] Use of 24-hour ambulatory blood pressure monitoring (ABPM) to assess antihypertensive efficacy: A comparison of olmesartan medoxomil (OLM) and amlodipine besylate (AML)
    Marbury, TC
    Silfani, TN
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 68A - 68A
  • [22] Blood pressure (BP)-lowering efficacy of olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) and benazepril (BN) plus amlodipine (AML) in patients (pts) stratified by age and gender
    Punzi, H.
    Kereiakes, D.
    Xu, J.
    Lipka, L.
    Chavanu, K.
    Dubiel, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S468 - S468
  • [23] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) BASED ON SEVERITY OF HYPERTENSION: THE TRINITY STUDY
    Kereiakes, D.
    Chrysant, S. G.
    Melino, M.
    Fernandez, V.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E97 - E97
  • [24] SAFETY AND TOLERABILITY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY
    Chrysant, S. G.
    Oparil, S.
    Melino, M.
    Fernandez, V.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E97 - E98
  • [25] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN BLACK AND NON-BLACK PATIENTS: THE TRINITY STUDY
    Oparil, S.
    Littlejohn, T.
    Melino, M.
    Fernandez, V.
    Lee, J.
    Heyrman, R.
    ETHNICITY & DISEASE, 2010, 20 (04) : S39 - S39
  • [26] Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
    Chrysant, S. G.
    Lee, J.
    Melino, M.
    Karki, S.
    Heyrman, R.
    JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (11) : 730 - 738
  • [27] Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
    S G Chrysant
    J Lee
    M Melino
    S Karki
    R Heyrman
    Journal of Human Hypertension, 2010, 24 : 730 - 738
  • [28] Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy A Randomized, Double-Blind, Parallel-Group, Multicentre Study
    Barrios, Vivencio
    Brommer, Peter
    Haag, Uwe
    Calderon, Alberto
    Escobar, Carlos
    CLINICAL DRUG INVESTIGATION, 2009, 29 (07) : 427 - 439
  • [29] Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after MonotherapyA Randomized, Double-Blind, Parallel-Group, Multicentre Study
    Vivencio Barrios
    Peter Brommer
    Uwe Haag
    Alberto Calderón
    Carlos Escobar
    Clinical Drug Investigation, 2009, 29 : 427 - 439
  • [30] CLINICAL AND PATIENT-REPORTED OUTCOMES OF TRIPLE COMBINATION OF OLMESARTAN MEDOXOMIL (OM), AMLODIPINE BESYLATE (AML) AND HYDROCHLOROTHIAZIDE (HCT) IN HYPERTENSIVE PATIENTS
    Ehlken, B.
    Claus, V
    Shlaen, R.
    Oberdiek, A. M. S.
    VALUE IN HEALTH, 2011, 14 (07) : A385 - A385
12345